{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:29:51Z","timestamp":1770352191691,"version":"3.49.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pain Management"],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.1080\/17581869.2025.2494495","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T08:47:02Z","timestamp":1745830022000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Methadone to treat chemotherapy-induced peripheral neuropathy (METACIN): study protocol"],"prefix":"10.1080","volume":"15","author":[{"given":"Mathieos","family":"Belayneh","sequence":"first","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"BC Cancer Pain and Symptom Management\/Palliative Care, Vancouver and Surrey, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Hejazi","sequence":"additional","affiliation":[{"name":"Providence Health Services Authority","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval","place":["Quebec, Canada"]},{"name":"Universit\u00e9 Laval","place":["Quebec, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Hawley","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"BC Cancer Pain and Symptom Management\/Palliative Care, Vancouver and Surrey, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000500"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2021.09.004"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2813"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3329-5"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1155\/2003\/236718"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.06.025"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003971.pub4"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2021.0309"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyab081"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.172"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006146.pub2"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.03.022"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/pmr.2023.0018"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.01.013"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.10.017"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0724-4"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2836"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00048-2"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(86)80042-2"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.11.3656"},{"key":"e_1_3_5_24_1","first-page":"1","article-title":"Symptom management guidelines: chemotherapy \u2013 induced peripheral neuropathy (CIPN)","author":"Buduhan V","year":"2019","unstructured":"Buduhan V, Cashman R, Cooper E, et al. Symptom management guidelines: chemotherapy \u2013 induced peripheral neuropathy (CIPN). BC Cancer. 2019:1\u20138.","journal-title":"BC Cancer"},{"key":"e_1_3_5_25_1","first-page":"1","article-title":"Chemotherapy induced peripheral neuropathy guideline resource unit guru@ahs.Ca","author":"Health Services A","year":"2019","unstructured":"Health Services A. Chemotherapy induced peripheral neuropathy guideline resource unit guru@ahs.Ca. Guidel Resour Unit. 2019:1\u201313.","journal-title":"Guidel Resour Unit"},{"key":"e_1_3_5_26_1","first-page":"6","volume-title":"Regulations amending the narcotic control regulations and the New classes of practitioners regulations (diacetylmorphine (heroin) and methadone): sOR\/2018\u201337","author":"Government of Canada","year":"2018","unstructured":"Government of Canada. Regulations amending the narcotic control regulations and the New classes of practitioners regulations (diacetylmorphine (heroin) and methadone): sOR\/2018\u201337. Vol. 152. Canada Gazette. Canada: Canada Gazette; 2018. p. 6."},{"key":"e_1_3_5_27_1","first-page":"1","article-title":"Methadone for pain management in chemotherapy-induced peripheral neuropathy: a retrospective review","author":"Boen C","year":"2024","unstructured":"Boen C, Ridley J, Hawley P. Methadone for pain management in chemotherapy-induced peripheral neuropathy: a retrospective review. J Pain Palliat Care Pharmacother. 2024 Jul;38:1\u201310.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3664-y"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00882-6"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-015-0810-y"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.06.002"},{"key":"e_1_3_5_32_1","unstructured":"The University of Texas MD Anderson Cancer Center. Brief pain inventory (short form) [Internet]. 2024 [cited 2024 Jan 26]. Available from: https:\/\/www.mdanderson.org\/research\/departments-labs-institutes\/departments-divisions\/symptom-research\/symptom-assessment-tools\/brief-pain-inventory.html"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6533797"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01493-y"},{"key":"e_1_3_5_35_1","unstructured":"National Institute of Mental Health. Mapi research trust. Patient global impressions scale - change improvement severity (PGI-C PGI-I PGI-S). 2024 [cited 2024 Apr 12]. Available from: https:\/\/eprovide.mapi-trust.org\/instruments\/patient-global-impressions-scale-change-improvement-severity#languages"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1378"},{"key":"e_1_3_5_37_1","unstructured":"National Cancer Institute. Division of Cancer Treatment & Diagnosis. Common terminology criteria for adverse events (CTCAE). 2021 [cited 2024 Jan 26]. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htmhttps:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-022-00156-x"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12443"},{"key":"e_1_3_5_40_1","unstructured":"Center for Biologics Evaluation and Research Center for Devices and Radiological Health Center for Drug Evaluation and Research. FDA. Guidance for clinical trial sponsors: establishment and operation of clinical trial data monitoring committees. 2006 [cited 2024 Apr 15]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/establishment-and-operation-clinical-trial-data-monitoring-committees"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-018-0099-x"},{"key":"e_1_3_5_42_1","volume-title":"Product monograph including patient medication information apo-methadone methadone hydrochloride tablets 1 mg, 5 mg, 10 mg and 25 mg submission control No : 2582","author":"Apotex Inc","year":"2021","unstructured":"Apotex Inc. Product monograph including patient medication information apo-methadone methadone hydrochloride tablets 1 mg, 5 mg, 10 mg and 25 mg submission control No : 2582. Tor(ON)to, (ON), Canada: Apotex Inc; 2021."},{"key":"e_1_3_5_43_1","volume-title":"Product monograph apo-duloxetine duloxetine delayed-release capsules 30mg and 60mg","author":"Apotex Inc","year":"2021","unstructured":"Apotex Inc. Product monograph apo-duloxetine duloxetine delayed-release capsules 30mg and 60mg. Tor(ON)to, (ON), Canada: Apotex Inc; 2021."}],"container-title":["Pain Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17581869.2025.2494495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:27:30Z","timestamp":1748269650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17581869.2025.2494495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,4]]}},"alternative-id":["10.1080\/17581869.2025.2494495"],"URL":"https:\/\/doi.org\/10.1080\/17581869.2025.2494495","relation":{},"ISSN":["1758-1869","1758-1877"],"issn-type":[{"value":"1758-1869","type":"print"},{"value":"1758-1877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}